Cell Isolation Market Size (2024 - 2029)

Cell Isolation Market Analysis

The Cell Isolation Market size is estimated at USD 13.84 billion in 2024, and is expected to reach USD 26.47 billion by 2029, growing at a CAGR of 13.85% during the forecast period (2024-2029).

The COVID-19 pandemic has created a lucrative opportunity for researchers to study and understand the new infectious virus and develop treatments and diagnostic tools for it. Several pharmaceutical and biotech giants have been conducting rapid and extensive R&D activities to develop novel vaccines, therapies, and testing kits. This factor has significantly boosted the demand for cell isolation tools in research applications. For instance, in February 2021, the National Institute of Health of the United States launched an initiative worth USD 1.5 billion for over four years to fund investigations on "Long COVID: Long-term Effects of COVID-19". Therefore, due to such developments, the COVID-19 pandemic is expected to significantly impact the market's growth.

Cell isolation plays an important role in various applications, including biologics design and development, therapeutic protein production, in-vitro diagnostics, and other research applications. The rising prevalence of chronic and infectious diseases, such as cancer and COVID-19, and continuous government initiatives to improve the biotechnology industry are the major driving factors contributing to the market's growth. For instance, according to the American Cancer Society's 2021 report, about 1.9 million cancer cases (970,250 in males and 927,910 in females) were diagnosed in 2021 in the United States. Thus, the use of cell isolation products is expected to increase over the years for the detection, diagnosis, and administration of proper therapies to the patient. This factor may, in turn, boost the growth of the market studied.

The new investments in biotechnology and life sciences are also expected to have a significant impact on the growth of the market. These new investments may drive the demand for cell isolation products and services and lead to advancements in cell isolation technology with ongoing research activities. For instance, in August 2021, Hyderabad (India)-based Sai Life Sciences, a contract R&D and manufacturing organization, revealed its plan of investing about INR 450 crore at its integrated R&D campus in Hyderabad by 2023, to expand and enhance its R&D and manufacturing facilities and other activities.

Technological advancements and innovations in the area of cell isolation or separation are expected to augment the growth of the market. These advancements may increase the efficiency of the products and reduce their cost, thus leading to greater adoption of cell isolation products like instruments and kits. For instance, in March 2022, Thermo Fisher Scientific introduced the new, fully-customizable Gibco CTS Xenon Electroporation System, which enables large-scale cell therapy development and clinical manufacturing. Gibco CTS Xenon Electroporation System complements Thermo Fisher Scientific's portfolio of end-to-end cell therapy solutions. Hence, such innovations and product launches are expected to fuel growth in the cell isolation market during the forecast period.

However, factors such as strict regulations and compliance with cell isolation products by different countries are expected to restrain the growth of the cell isolation market during the forecast period.

Cell Isolation Industry Segmentation

As per the scope of the report, cell isolation or cell separation is a technique used to sort cells into specific populations from a heterogeneous group of cells without contamination. This technique helps cell-based therapies to improve the quality of treatment and clinical outcomes. The cell isolation market is segmented by product (consumables (reagents and kits, beads, and disposables) and instruments (centrifuges, flow cytometers, filtration systems, magnetic-activated cell separator systems, other instruments)), type (human and animal), application (research laboratories and institutes, biotechnology and pharmaceutical companies, and other applications), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value in USD million for the abovementioned segments.